Target intelligence / Profile preview

Staphylococcus aureus cell-surface receptors (MSCRAMMs)

Target
MSCRAMMs
Molecular classification
Receptor, Other
01

Overview

Staphylococcus aureus cell-surface receptors, primarily comprising the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) and other cell wall-anchored (CWA) proteins, are critical virulence factors that mediate the bacterium's interaction with the host [3, 4]. These proteins, such as Clumping factor A (ClfA), Fibronectin-binding proteins (FnBPs), and Protein A (Spa), are covalently attached to the peptidoglycan layer by the enzyme sortase A [3, 8]. They play essential roles in the initial stages of infection by facilitating adhesion to host extracellular matrix components (e.g., fibrinogen, fibronectin, collagen) and promoting the formation of biofilms, which protect the bacteria from antibiotics and the immune system [6, 14]. Additionally, these receptors contribute to immune evasion by binding to the Fc region of antibodies (Protein A) or interfering with the complement system [11]. Given their surface exposure and vital roles in pathogenesis, they are prime targets for the development of vaccines and monoclonal antibodies, such as Tefibazumab, which aims to neutralize their function and enhance bacterial clearance [10, 11]. However, the therapeutic targeting of these receptors is complicated by their high degree of redundancy and the significant genetic diversity across different S. aureus strains [11, 13].

Other names
Microbial Surface Components Recognizing Adhesive Matrix MoleculesCell wall-anchored proteinsCWA proteinsStaphylococcal adhesinsStaphylococcal surface proteins
02

Mechanism of action

Inhibition of bacterial adhesion to host extracellular matrix components, prevention of biofilm development, and neutralization of immune evasion mechanisms to facilitate opsonophagocytosis and bacterial clearance [3, 8, 11].

03

Biological functions

Immune responseOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Functional redundancy among surface proteinsHigh strain variability and antigenic diversityPotential for rapid emergence of resistanceHistory of clinical trial failures for anti-staphylococcal biologics
06

Interacting drugs

Tefibazumab

3 more in the full profile.

07

Biomarkers

Presence of clfA genePresence of fnbA/B genesPresence of spa geneBiofilm-forming phenotypeAnti-MSCRAMM antibody titers

Beyond the preview

Go deeper on Staphylococcus aureus cell-surface receptors (MSCRAMMs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus cell-surface receptors (MSCRAMMs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call